{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T02:28:59Z","timestamp":1790908139868,"version":"4.1.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1097\/mbc.0b013e3283079e46","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T18:52:31Z","timestamp":1236279151000},"page":"453-457","source":"Crossref","is-referenced-by-count":4,"title":["Evidence of jak2 val617phe positive essential thrombocythemia with splanchnic thrombosis during estroprogestinic treatment"],"prefix":"10.1097","volume":"19","author":[{"given":"Mario","family":"Lapecorella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Tabilio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Lucchesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariasanta","family":"Napolitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Colagrande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Di Ianni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guglielmo","family":"Mariani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-21-20210203","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJM197610212951702","article-title":"Polycythemia vera: stem-cell and probable clonal origin of the disease","volume":"295","author":"Adamson","year":"1976","journal-title":"N Engl J Med"},{"key":"R2-21-20210203","doi-asserted-by":"crossref","first-page":"6848","DOI":"10.1073\/pnas.88.15.6848","article-title":"Clonality in myeloproliferative disorders: analysis by means of the polymerase chain reaction","volume":"88","author":"Gilliland","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R3-21-20210203","first-page":"381","article-title":"Cytogenetic findings in untreated patients with essential thrombocythemia","volume":"20","author":"Panani","year":"2006","journal-title":"In Vivo"},{"key":"R4-21-20210203","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000064754","article-title":"Cytogenetic and molecular genetic aspects of essential thrombocythemia","volume":"108","author":"Steensma","year":"2002","journal-title":"Acta Haematol"},{"key":"R5-21-20210203","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(05)71142-9","article-title":"Cancer Genome Project. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders","volume":"365","author":"Baxter","year":"2005","journal-title":"Lancet"},{"key":"R6-21-20210203","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1038\/sj.leu.2404649","article-title":"A higher JAK2 V617F-mutated clone is observed in platelets than in granulocytes from essential thrombocythemia patients, but not in patients with polycythemia vera and primary myelofibrosis","volume":"21","author":"Bellosillo","year":"2007","journal-title":"Leukemia"},{"key":"R7-21-20210203","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1182\/blood-2006-01-013540","article-title":"The JAK2-V617F mutation is frequently present at diagnosis in patients with essential thrombocythemia and polycythemia vera","volume":"108","author":"Lippert","year":"2006","journal-title":"Blood"},{"key":"R8-21-20210203","doi-asserted-by":"crossref","first-page":"4139","DOI":"10.1182\/blood-2005-09-3900","article-title":"X-inactivation-based clonality analysis and quantitative JAK2V617F assessment reveal a strong association between clonality and JAK2V617F in PV but not ET\/MMM, and identifies a subset of JAK2V617F-negative ET and MMM patients with clonal hematopoiesis","volume":"107","author":"Levine","year":"2006","journal-title":"Blood"},{"key":"R9-21-20210203","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0049-3848(02)00354-7","article-title":"Markers of platelet activation and platelet-leukocyte interaction in patients with myeloproliferative syndromes","volume":"108","author":"Villmow","year":"2002","journal-title":"Thromb Res"},{"key":"R10-21-20210203","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1182\/blood.V96.13.4261","article-title":"Polymorphonuclear leukocyte activation and hemostasis in patients with essential thrombocythemia and polycythemia vera","volume":"96","author":"Falanga","year":"2000","journal-title":"Blood"},{"key":"R11-21-20210203","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/S0140-6736(05)67785-9","article-title":"Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study","volume":"366","author":"Campbell","year":"2005","journal-title":"Lancet"},{"key":"R12-21-20210203","first-page":"169","article-title":"Increased platelet and leukocyte activation as contributing mechanisms for thrombosis in essential thrombocythemia and correlation with the JAK2 mutational status","volume":"91","author":"Arellano-Rodrigo","year":"2006","journal-title":"Haematologica"},{"key":"R13-21-20210203","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1111\/j.1538-7836.2007.02626.x","article-title":"Platelet and coagulation activation markers in myeloproliferative diseases: relationships with JAK2 V6I7 F status, clonality, and antiphospholipid antibodies","volume":"5","author":"Robertson","year":"2007","journal-title":"J Thromb Haemost"},{"key":"R14-21-20210203","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1038\/sj.leu.2404360","article-title":"A microelectronic DNA chip detects the V617F JAK-2 mutation in myeloproliferative disorders","volume":"20","author":"Di Ianni","year":"2006","journal-title":"Leukemia"},{"key":"R15-21-20210203","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1538-7836.2006.02277.x","article-title":"The JAK2 V617F mutation frequently occurs in patients with portal and mesenteric venous thrombosis","volume":"5","author":"Colaizzo","year":"2007","journal-title":"J Thromb Haemost"},{"key":"R16-21-20210203","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/j.1538-7836.2007.02424.x","article-title":"Incidence of the JAK2 V617F mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders","volume":"5","author":"De Stefano","year":"2007","journal-title":"J Thromb Haemost"},{"key":"R17-21-20210203","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa043800","article-title":"Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia","volume":"353","author":"Harrison","year":"2005","journal-title":"N Engl J Med"},{"key":"R18-21-20210203","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1055\/s-0038-1657547","article-title":"Oral contraceptives and thrombotic disease: risk of venous thromboembolism","volume":"78","author":"Helmerhorst","year":"1997","journal-title":"Thromb Haemost"},{"key":"R19-21-20210203","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1056\/NEJM200105173442007","article-title":"Oral contraceptives and the risk of venous thrombosis","volume":"344","author":"Vandenbroucke","year":"2001","journal-title":"N Engl J Med"},{"key":"R20-21-20210203","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1055\/s-0037-1614089","article-title":"Regulation of platelet aggregation and adenosine triphosphate release in vitro by 17beta-estradiol and medroxyprogesterone acetate in postmenopausal women","volume":"84","author":"Bar","year":"2000","journal-title":"Thromb Haemost"},{"key":"R21-21-20210203","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/00001721-200207000-00009","article-title":"Alterations in platelet function during the ovarian cycle","volume":"13","author":"Feuring","year":"2002","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R22-21-20210203","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/09537100600936224","article-title":"Effect of oral contraceptives and ovarian cycle on platelet function","volume":"18","author":"Roell","year":"2007","journal-title":"Platelets"},{"key":"R23-21-20210203","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/MBC.0b013e3281a3bed8","article-title":"Upper extremity deep vein thrombosis after suspension of progesterone-only oral treatment","volume":"18","author":"Lapecorella","year":"2007","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R24-21-20210203","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1182\/blood.V95.7.2289","article-title":"Human megakaryocytes and platelets contain the estrogen receptor beta and androgen receptor (AR): testosterone regulates AR expression","volume":"95","author":"Khetawat","year":"2000","journal-title":"Blood"},{"key":"R25-21-20210203","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/bmj.312.7023.83","article-title":"Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women","volume":"312","author":"Spitzer","year":"1996","journal-title":"BMJ"},{"key":"R26-21-20210203","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1160\/TH07-09-0570","article-title":"Venous thrombosis in oral contraceptive users and the presence of the JAK2 V617F mutation","volume":"99","author":"Grandone","year":"2008","journal-title":"Thromb Haemost"},{"key":"R27-21-20210203","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/ajh.10254","article-title":"Thrombophilic genotypes, natural anticoagulants, and plasma homocysteine in myeloproliferative disorders: relationship with splanchnic vein thrombosis and arterial disease","volume":"72","author":"Amitrano","year":"2003","journal-title":"Am J Hematol"},{"key":"R28-21-20210203","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1182\/blood-2006-06-029769","article-title":"Long-term serial analysis of X-chromosome inactivation patterns and JAK2 V617F mutant levels in patients with essential thrombocythemia show that minor mutant-positive clones can remain stable for many years","volume":"109","author":"Gale","year":"2007","journal-title":"Blood"},{"key":"R29-21-20210203","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1128\/MCB.25.12.4826-4840.2005","article-title":"Progestins induce transcriptional activation of signal transducer and activator of transcription 3 (Stat3) via a Jak- and Src-dependent mechanism in breast cancer cells","volume":"25","author":"Proietti","year":"2005","journal-title":"Mol Cell Biol"},{"key":"R30-21-20210203","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1182\/blood-2007-01-069237","article-title":"Different STAT-3 and STAT-5 phosphorylation discriminates among Ph-negative chronic myeloproliferative diseases and is independent of the V617F JAK-2 mutation","volume":"110","author":"Teofili","year":"2007","journal-title":"Blood"},{"key":"R31-21-20210203","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S0301-472X(01)00637-3","article-title":"STAT3 is constitutively active in some patients with polycythemia rubra vera","volume":"29","author":"Roder","year":"2001","journal-title":"Exp Hematol"},{"key":"R32-21-20210203","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/ajh.21159","article-title":"Clinical JAK2V617F mutation testing: Limited utility for general hospital patients with venous and arterial thromboses in common locations","volume":"83","author":"Abel","year":"2008","journal-title":"Am J Hematol"}],"container-title":["Blood Coagulation & Fibrinolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00001721-200807000-00021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:09:52Z","timestamp":1618034992000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001721-200807000-00021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/mbc.0b013e3283079e46","relation":{},"ISSN":["0957-5235"],"issn-type":[{"value":"0957-5235","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}